...
机译:用造影强度特征预测胰腺神经内分泌肿瘤淋巴结转移
Department of Surgery Division of Hepato-Biliary-Pancreatic Surgery Kobe University Graduate;
Department of Surgery Division of Hepato-Biliary-Pancreatic Surgery Kobe University Graduate;
Department of Surgery Division of Hepato-Biliary-Pancreatic Surgery Kobe University Graduate;
Department of Surgery Division of Hepato-Biliary-Pancreatic Surgery Kobe University Graduate;
Department of Surgery Division of Hepato-Biliary-Pancreatic Surgery Kobe University Graduate;
Department of Surgery Division of Hepato-Biliary-Pancreatic Surgery Kobe University Graduate;
Department of Surgery Division of Hepato-Biliary-Pancreatic Surgery Kobe University Graduate;
Department of Radiology Kobe University Graduate School of Medicine;
Department of Surgery Division of Hepato-Biliary-Pancreatic Surgery Kobe University Graduate;
Department of Surgery Division of Hepato-Biliary-Pancreatic Surgery Kobe University Graduate;
Department of Surgery Division of Hepato-Biliary-Pancreatic Surgery Kobe University Graduate;
Contrast-enhanced computed tomography; Lymph node metastasis; Pancreatic neuroendocrine tumor;
机译:用对比增强特性对胰腺神经内分泌肿瘤淋巴结转移预测的评论
机译:用对比增强特性对胰腺神经内分泌肿瘤淋巴结转移预测的评论
机译:用造影强度特征预测胰腺神经内分泌肿瘤淋巴结转移
机译:使用4D CNN从初级乳腺肿瘤临床DCE MRI的淋巴结转移的术前预测
机译:LCP纳米颗粒用于肿瘤和淋巴结转移成像。
机译:淋巴结比率而非所检查的淋巴结总数或淋巴结转移总数是手术切除后胰腺神经内分泌肿瘤整体生存的预测指标
机译:表3.4.a.1胰头肿瘤中肿瘤的淋巴结转移表3.4.a.2胰腺体中肿瘤或尾部的淋巴结转移表3.4.a.3淋巴结转移来自肿瘤胰腺的两个区域表3.4.a.4淋巴结转移来自整个胰腺的肿瘤
机译:乳腺癌淋巴结转移的分子机制